Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether additional doses of ipilimumab have a
positive effect on survival in the treatment of advanced melanoma that has progressed after
successful initial treatment with ipilimumab.